Number of isolates tested for extended-spectrum cephalosporins in Latvia
Latvia: Number of isolates tested for extended-spectrum cephalosporins was 5 in 2018. ◆ Volatile
Number of isolates tested for extended-spectrum cephalosporins in Latvia, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for number of isolates tested for extended-spectrum cephalosporins in Latvia is 5, measured in 2018.
That represents a change of up 25.0% on the previous year and down 44.4% over ten years.
Over the whole period, number of isolates tested for extended-spectrum cephalosporins in Latvia peaked at 39 in 2012 and was at its lowest, 4, in 2017.
That places Latvia 49th out of 51 countries with data for 2018, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Number of isolates tested for extended-spectrum cephalosporins in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 9 | — |
| 2010 | 20 | +122.2% |
| 2011 | 28 | +40.0% |
| 2012 | 39 | +39.3% |
| 2013 | 38 | -2.6% |
| 2014 | 21 | -44.7% |
| 2015 | 9 | -57.1% |
| 2016 | 8 | -11.1% |
| 2017 | 4 | -50.0% |
| 2018 | 5 | +25.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9 | 9 | 9 | 1 |
| 2010s | 19.11 | 4 | 39 | 9 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is number of isolates tested for extended-spectrum cephalosporins in Latvia?
- Number of isolates tested for extended-spectrum cephalosporins in Latvia was 5 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest number of isolates tested for extended-spectrum cephalosporins recorded in Latvia?
- The highest recorded value was 39 in 2012.
- What is the lowest number of isolates tested for extended-spectrum cephalosporins recorded in Latvia?
- The lowest recorded value was 4 in 2017.
- How does Latvia rank for number of isolates tested for extended-spectrum cephalosporins?
- Latvia ranks 49th out of 51 countries with data for 2018.
- Is number of isolates tested for extended-spectrum cephalosporins rising or falling in Latvia?
- Over the last ten years it is down 44.4%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Number of isolates tested for extended-spectrum cephalosporins. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).